Jazz Pharmaceuticals
JAZZ
#2007
Rank
A$14.35 B
Marketcap
A$236.21
Share price
0.31%
Change (1 day)
16.69%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -A$1.07 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$4.15 Billion. In 2024 the company made an earning of A$0.67 Billion, an increase over its 2023 earnings that were of A$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.07 Billion-257.87%
2024 A$0.67 B57.87%
2023 A$0.42 B-179.92%
2022 -A$0.54 Billion230.37%
2021 -A$0.17 Billion-141.02%
2020 A$0.39 B-39.45%
2019 A$0.65 B-14.2%
2018 A$0.76 B20.03%
2017 A$0.63 B-17.15%
2016 A$0.76 B22.14%
2015 A$0.62 B187.64%
2014 A$0.21 B-50.79%
2013 A$0.44 B73.63%
2012 A$0.25 B41.69%
2011 A$0.17 B116.61%
2010 A$82.98 M262.77%
2009 A$22.87 M-111.33%
2008 -A$0.21 Billion1.31%
2007 -A$0.2 Billion77.8%
2006 -A$0.12 Billion36.59%
2005 -A$82.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.57 B-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$3.01 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-A$3.44 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$2.54 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel